首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1871899

樺木酸市場預測至2032年：按來源、形態、純度、應用、最終用戶和地區分類的全球分析

Betulinic Acid Market Forecasts to 2032 - Global Analysis By Source (Natural Source and Synthetic Source), Form, Purity, Application, End User and By Geography

出版日期: 2025年11月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 預測，2025 年全球樺木酸市場價值將達到 1 億美元，預計到 2032 年將達到 3.3 億美元。

預計在預測期內，樺木酸的複合年成長率將達到17.7%。樺木酸是一種天然的五環三萜類化合物，主要存在於樺樹皮和多種藥用植物中。它具有多種治療作用，包括抗癌、抗病毒、抗菌和抗發炎特性。其作用機轉包括誘導癌細胞凋亡、抑制病毒增生、對抗氧化傷害。由於其生物活性和廣泛的藥理潛力，樺木酸在未來的藥物研究和臨床應用方面具有巨大的前景。

全球癌症發生率不斷上升

隨著腫瘤學研究的活性化，天然抗癌物質因其治療潛力而備受關注。樺木酸因其對癌細胞的選擇性細胞毒性而聞名，目前正被擴大用於臨床應用和作為膳食補充劑。人口老化和診斷技術的進步推動了對標靶癌症治療的需求。製藥和膳食補充劑生產商正加大對植物來源分子的研發投入，以期開發出能夠輔助傳統治療方法的藥物，預計這一趨勢將加速樺木酸在癌症預防和治療領域的應用。

原料取得困難

季節性收穫週期和地理限制制約了產量原料的取得。確保永續的原料來源仍然是一項挑戰，尤其對於那些尋求擴大生產規模的製造商而言更是如此。圍繞森林砍伐和生物多樣性保護的監管壓力進一步加劇了原料採購的複雜性。小規模生產商在確保可靠的供應鏈方面面臨成本障礙和物流挑戰。這些限制可能會減緩市場擴張，並增加對合成替代品的依賴。

合成和萃取技術的進步

綠色化學方法和酵素技術在提高產量和純度的同時，也降低了對環境的影響。研究人員正在開發可擴展的生物技術工藝，以克服原料的限制。這些創新降低了生產成本，並擴大了其商業應用範圍。改進的萃取通訊協定也促進了這些技術在藥物製劑和機能性食品中的應用。隨著技術的成熟，預計它將推動市場成長並擴大其可及性。

來自合成替代品的競爭

具有相似藥理特性的合成類似物的出現對天然樺木酸構成了競爭威脅。這些實驗室設計的化合物通常具有更高的均一性、擴充性和更清晰的監管規定。由於核准流程簡化和成本優勢，製藥公司可能會優先考慮合成方案。藥物化學的進步使得設計更有效的衍生物成為可能，這些衍生物能夠模擬樺木酸的抗癌特性。這種轉變可能導致對天然資源的投資減少，從而威脅到植物萃取物的市場佔有率。如果缺乏明確的差異化，天然樺木酸可能難以在高價值應用領域保持其地位。

新冠疫情的影響：

疫情擾亂了全球供應鏈，導致樺木酸的採購和生產計畫延誤。封鎖和勞動力短缺影響了採伐和加工作業，尤其是在森林資源豐富的地區。然而，這場危機也間接刺激了需求，激發了人們對具有免疫支持和抗病毒特性的化合物的興趣。疫情也促進了對樺木酸抗病毒特性的研究，包括其在新冠肺炎輔助性治療中的作用。後疫情時代的策略強調供應鏈韌性和植物活性成分來源多角化。

預計在預測期內，天然成分細分市場將佔據最大的市場佔有率。

由於其安全性、生物利用度以及消費者對植物來源成分的偏好，預計天然來源成分將在預測期內佔據最大的市場佔有率。樺木酸植物來源，因其抗炎和抗癌特性，成為膳食補充劑和化妝品的熱門成分。監管機構正透過潔淨標示計劃和傳統醫學框架，日益支持天然化合物。製造商正投資於永續採收和可追溯性，以滿足不斷成長的需求。人們對天然療法和整體健康理念的日益重視，也使這一細分市場受益匪淺。

預計在預測期內，營養補充品公司板塊的複合年成長率將最高。

預計在預測期內，營養保健品領域將實現最高成長率，這主要得益於消費者對預防保健和功能性補充劑日益成長的興趣。各公司正將樺木酸添加到旨在免疫力、消炎和預防癌症的產品中。潔淨標示運動和對植物來源活性成分的需求正在推動膠囊、粉劑和飲料領域的創新。與植物萃取物生產商和研究機構的策略合作正在加速產品開發。監管部門對營養保健品的支持正在幫助產品更快進入市場並拓展分銷管道。

佔比最大的地區：

亞太地區預計將在預測期內佔據最大的市場佔有率，這主要得益於其豐富的生物多樣性、不斷完善的醫療基礎設施以及對傳統藥物的強勁需求。中國、印度和韓國等國正在加大對植物藥研發的投入。政府主導的各項措施正在推動草藥成分融入主流醫療保健和膳食補充劑中。該地區的生產能力和成本優勢為樺木酸的大規模生產提供了支持。癌症發生率的上升以及消費者對天然療法的偏好正在推動市場成長。

預計年複合成長率最高的地區：

由於北美擁有強大的研發生態系統和植物來源源療法，預計該地區在預測期內將實現最高的複合年成長率。美國和加拿大正在增加對天然核准藥物和功能性成分的投資。監管機構正在簡化植物藥和膳食補充劑的核准流程。意識提升，推動了對樺木酸等生物活性化合物的需求。提取技術和產品形式的創新正在擴大市場滲透率。

免費客製化服務：

購買此報告的客戶可享有以下免費自訂選項之一：

公司概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 主要企業SWOT分析（最多3家公司）
區域細分
- 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
競爭基準化分析
- 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 其他歐洲
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 亞太其他地區
南美洲
- 阿根廷
- 巴西
- 智利
- 其他南美洲國家
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東和非洲地區

第11章重大進展

協議、夥伴關係、合作和合資企業
收購與併購
新產品上市
業務拓展
其他關鍵策略

第12章：企業概況

Thermo Fisher Scientific
Merck KGaA
Tokyo Chemical Industry（TCI）
Cayman Chemical Company
LGC Group
Selleck Chemicals
Abcam
ChemFaces
Biosynth
MedChemExpress
ChemScene
Chem Impex International
Spectrum Chemical
Extrasynthese
Aladdin Scientific

簡介目錄圖表

Product Code: SMRC32269

According to Stratistics MRC, the Global Betulinic Acid Market is accounted for $0.10 billion in 2025 and is expected to reach $0.33 billion by 2032 growing at a CAGR of 17.7% during the forecast period. Betulinic acid, a natural pentacyclic triterpenoid compound found mainly in birch bark and various medicinal plants, possesses multiple therapeutic properties such as anticancer, antiviral, antibacterial, and anti-inflammatory effects. It works by triggering apoptosis in tumor cells, suppressing viral growth, and combating oxidative damage. Owing to its bioactive nature and broad pharmacological potential, betulinic acid holds significant promise for future drug research and clinical use.

Market Dynamics:

Driver:

Rising global cancer incidence

As oncology research intensifies, natural anticancer agents are gaining traction for their therapeutic potential. Betulinic acid, known for its selective cytotoxicity against tumor cells, is increasingly being explored in clinical and nutraceutical applications. Aging populations and improved diagnostic capabilities are expanding the demand for targeted cancer therapies. Pharmaceutical and nutraceutical firms are investing in plant-derived molecules to complement conventional treatments. This trend is expected to accelerate betulinic acid adoption across both preventive and therapeutic segments.

Restraint:

Limited availability of raw materials

Seasonal harvesting cycles and geographic limitations restrict access to high-yield raw materials. Sustainable sourcing remains a challenge, especially for manufacturers aiming to scale operations. Regulatory pressures around deforestation and biodiversity conservation further complicate raw material procurement. Smaller producers face cost barriers and logistical hurdles in securing reliable supply chains. These limitations may slow market expansion and increase dependency on synthetic alternatives.

Opportunity:

Advancements in synthesis/extraction technology

Green chemistry approaches and enzymatic techniques are improving yield and purity while reducing environmental impact. Researchers are developing scalable biotechnological processes to overcome raw material constraints. These innovations are lowering production costs and enabling broader commercial applications. Enhanced extraction protocols are also facilitating integration into pharmaceutical formulations and functional foods. As technology matures, it is expected to drive market growth and expand accessibility.

Threat:

Competition from synthetic substitutes

The emergence of synthetic analogs with similar pharmacological profiles poses a competitive threat to natural betulinic acid. These lab-engineered compounds often offer greater consistency, scalability, and regulatory clarity. Pharmaceutical firms may favor synthetic options due to streamlined approval pathways and cost advantages. Advances in medicinal chemistry are enabling the design of more potent derivatives that mimic betulinic acid's anticancer effects. This shift could divert investment away from natural sources and reduce market share for botanical extracts. Without clear differentiation, natural betulinic acid may struggle to maintain its position in high-value applications.

Covid-19 Impact:

The pandemic disrupted global supply chains, delaying raw material procurement and manufacturing timelines for betulinic acid. Lockdowns and labor shortages affected harvesting and processing operations, especially in forest-rich regions. However, the crisis also heightened interest in immune-supportive and antiviral compounds, indirectly benefiting demand. Research into betulinic acid's antiviral properties gained momentum, with some studies exploring its role in COVID-19 adjunct therapies. Post-pandemic strategies now emphasize supply chain resilience and diversified sourcing for botanical actives.

The natural source segment is expected to be the largest during the forecast period

The natural source segment is expected to account for the largest market share during the forecast period, due to its perceived safety, bioavailability, and consumer preference for plant-based ingredients. Betulinic acid derived from birch bark and other botanical sources is favored in nutraceuticals and cosmeceuticals for its anti-inflammatory and anticancer properties. Regulatory bodies are increasingly supporting natural compounds through clean-label initiatives and traditional medicine frameworks. Manufacturers are investing in sustainable harvesting and traceability to meet rising demand. The segment benefits from growing awareness of natural therapeutics and holistic wellness.

The nutraceutical companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the nutraceutical companies segment is predicted to witness the highest growth rate, due to rising consumer interest in preventive health and functional supplements. These firms are incorporating betulinic acid into formulations targeting immunity, inflammation, and cancer prevention. The clean-label movement and demand for plant-derived actives are driving innovation in capsules, powders, and beverages. Strategic partnerships with botanical extractors and research institutions are accelerating product development. Regulatory support for dietary supplements is enabling faster market entry and broader distribution.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its rich biodiversity, expanding healthcare infrastructure, and strong demand for traditional medicine. Countries like China, India, and South Korea are investing in botanical research and natural product development. Government initiatives are promoting the integration of herbal compounds into mainstream healthcare and nutraceuticals. The region's manufacturing capabilities and cost advantages support large-scale production of betulinic acid. Rising cancer incidence and consumer preference for natural remedies are fueling market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its robust R&D ecosystem and growing adoption of plant-based therapeutics. The U.S. and Canada are witnessing increased investment in natural oncology agents and functional ingredients. Regulatory agencies are streamlining pathways for botanical drug approvals and dietary supplements. Consumer awareness around cancer prevention and immune health is driving demand for bioactive compounds like betulinic acid. Innovation in extraction technologies and product formats is expanding market penetration.

Key players in the market

Some of the key players in Betulinic Acid Market include Thermo Fi, Merck KGa, Tokyo Che, Cayman Ch, LGC Group, Selleck Ch, Abcam, ChemFace, Biosynth, MedChem, ChemScen, Chem Imp, Spectrum, Extrasynt, and Aladdin S.

Key Developments:

In October 2025, Thermo Fisher Scientific Inc. announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.

In October 2025, Merck has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery. The agreement unites Merck's strength in organoids and synthetic chemistry with Promega's market leading assay and reporter technologies.

Sources Covered:

Natural Source
Synthetic Source

Forms Covered:

Powder
Liquid
Capsules

Purities Covered:

>=98% Purity
<98% Purity

Applications Covered:

Pharmaceuticals
Cosmetics & Personal Care
Food & Nutraceuticals
Chemical & Research Uses
Other Applications

End Users Covered:

Pharmaceutical Companies
Cosmetic Manufacturers
Research Laboratories
Nutraceutical Companies
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Betulinic Acid Market, By Source

5.1 Introduction
5.2 Natural Source
5.3 Synthetic Source

6 Global Betulinic Acid Market, By Form

6.1 Introduction
6.2 Powder
6.3 Liquid
6.4 Capsules

7 Global Betulinic Acid Market, By Purity

7.1 Introduction
7.2 >=98% Purity
7.3 <98% Purity

8 Global Betulinic Acid Market, By Application

8.1 Introduction
8.2 Pharmaceuticals
- 8.2.1 Anti-cancer Drugs
- 8.2.2 Anti-HIV Drugs
- 8.2.3 Anti-inflammatory Drugs
8.3 Cosmetics & Personal Care
- 8.3.1 Anti-aging Products
- 8.3.2 Skin Repair Formulations
8.4 Food & Nutraceuticals
- 8.4.1 Dietary Supplements
- 8.4.2 Functional Foods
8.5 Chemical & Research Uses
8.6 Other Applications

9 Global Betulinic Acid Market, By End User

9.1 Introduction
9.2 Pharmaceutical Companies
9.3 Cosmetic Manufacturers
9.4 Research Laboratories
9.5 Nutraceutical Companies
9.6 Other End Users

10 Global Betulinic Acid Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Thermo Fisher Scientific
12.2 Merck KGaA
12.3 Tokyo Chemical Industry (TCI)
12.4 Cayman Chemical Company
12.5 LGC Group
12.6 Selleck Chemicals
12.7 Abcam
12.8 ChemFaces
12.9 Biosynth
12.10 MedChemExpress
12.11 ChemScene
12.12 Chem Impex International
12.13 Spectrum Chemical
12.14 Extrasynthese
12.15 Aladdin Scientific

簡介目錄圖表

List of Tables

Table 1 Global Betulinic Acid Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Betulinic Acid Market Outlook, By Source (2024-2032) ($MN)
Table 3 Global Betulinic Acid Market Outlook, By Natural Source (2024-2032) ($MN)
Table 4 Global Betulinic Acid Market Outlook, By Synthetic Source (2024-2032) ($MN)
Table 5 Global Betulinic Acid Market Outlook, By Form (2024-2032) ($MN)
Table 6 Global Betulinic Acid Market Outlook, By Powder (2024-2032) ($MN)
Table 7 Global Betulinic Acid Market Outlook, By Liquid (2024-2032) ($MN)
Table 8 Global Betulinic Acid Market Outlook, By Capsules (2024-2032) ($MN)
Table 9 Global Betulinic Acid Market Outlook, By Purity (2024-2032) ($MN)
Table 10 Global Betulinic Acid Market Outlook, By >=98% Purity (2024-2032) ($MN)
Table 11 Global Betulinic Acid Market Outlook, By <98% Purity (2024-2032) ($MN)
Table 12 Global Betulinic Acid Market Outlook, By Application (2024-2032) ($MN)
Table 13 Global Betulinic Acid Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 14 Global Betulinic Acid Market Outlook, By Anti-cancer Drugs (2024-2032) ($MN)
Table 15 Global Betulinic Acid Market Outlook, By Anti-HIV Drugs (2024-2032) ($MN)
Table 16 Global Betulinic Acid Market Outlook, By Anti-inflammatory Drugs (2024-2032) ($MN)
Table 17 Global Betulinic Acid Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
Table 18 Global Betulinic Acid Market Outlook, By Anti-aging Products (2024-2032) ($MN)
Table 19 Global Betulinic Acid Market Outlook, By Skin Repair Formulations (2024-2032) ($MN)
Table 20 Global Betulinic Acid Market Outlook, By Food & Nutraceuticals (2024-2032) ($MN)
Table 21 Global Betulinic Acid Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 22 Global Betulinic Acid Market Outlook, By Functional Foods (2024-2032) ($MN)
Table 23 Global Betulinic Acid Market Outlook, By Chemical & Research Uses (2024-2032) ($MN)
Table 24 Global Betulinic Acid Market Outlook, By Other Applications (2024-2032) ($MN)
Table 25 Global Betulinic Acid Market Outlook, By End User (2024-2032) ($MN)
Table 26 Global Betulinic Acid Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
Table 27 Global Betulinic Acid Market Outlook, By Cosmetic Manufacturers (2024-2032) ($MN)
Table 28 Global Betulinic Acid Market Outlook, By Research Laboratories (2024-2032) ($MN)
Table 29 Global Betulinic Acid Market Outlook, By Nutraceutical Companies (2024-2032) ($MN)
Table 30 Global Betulinic Acid Market Outlook, By Other End Users (2024-2032) ($MN)